These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21214297)

  • 1. The Cromer blood group system: a review.
    Storry JR; Reid ME; Yazer MH
    Immunohematology; 2010; 26(3):109-18. PubMed ID: 21214297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cromer blood group system: a review.
    Storry JR; Reid ME
    Immunohematology; 2002; 18(4):95-103. PubMed ID: 15373545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three new high-prevalence antigens in the Cromer blood group system.
    Hue-Roye K; Lomas-Francis C; Belaygorod L; Lublin DM; Barnes J; Chung A; Fung-Kee-Fung K; Kinney J; Goldman-Lavi R; Yahalom V; Poole J; Ivankovic Z; Alcantara D; Bekavac M; Cepulic BG; Velliquette RW; Mason R; Reid ME
    Transfusion; 2007 Sep; 47(9):1621-9. PubMed ID: 17725726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel molecular basis of an Inab phenotype.
    Hue-Roye K; Powell VI; Patel G; Lane D; Maguire M; Chung A; Reid ME
    Immunohematology; 2005; 21(2):53-5. PubMed ID: 15954804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decay-accelerating factor (CD55) deficiency phenotypes in Japanese.
    Daniels GL; Green CA; Mallinson G; Okubo Y; Hori Y; Kataoka A; Kaihara M
    Transfus Med; 1998 Jun; 8(2):141-7. PubMed ID: 9675792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Cromer and DAF: role in health and disease.
    Lublin DM
    Immunohematology; 2005; 21(2):39-47. PubMed ID: 15954803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.
    Lublin DM; Mallinson G; Poole J; Reid ME; Thompson ES; Ferdman BR; Telen MJ; Anstee DJ; Tanner MJ
    Blood; 1994 Aug; 84(4):1276-82. PubMed ID: 7519480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.
    Telen MJ; Hall SE; Green AM; Moulds JJ; Rosse WF
    J Exp Med; 1988 Jun; 167(6):1993-8. PubMed ID: 2455016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy.
    Reid ME; Chandrasekaran V; Sausais L; Pierre J; Bullock R
    Vox Sang; 1996; 71(1):48-50. PubMed ID: 8837357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequestration of anti-Cra in the placenta: serologic demonstration by placental elution.
    Weber SL; Bryant BJ; Indrikovs AJ
    Transfusion; 2005 Aug; 45(8):1327-30. PubMed ID: 16078921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of Cromer blood group antigens.
    Lublin DM; Kompelli S; Storry JR; Reid ME
    Transfusion; 2000 Feb; 40(2):208-13. PubMed ID: 10686005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cromer-related antigens--blood group determinants on decay-accelerating factor.
    Daniels G
    Vox Sang; 1989; 56(4):205-11. PubMed ID: 2474898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D analysis of CROMER (DAF) and a new antigen CRAG.
    Floch A; Vege S; Hue-Roye K; Hamilton JR; Williams LA; Choate J; Lomas-Francis C; Westhoff CM
    Blood Transfus; 2022 Nov; 20(6):483-488. PubMed ID: 35175190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency).
    Reid ME; Mallinson G; Sim RB; Poole J; Pausch V; Merry AH; Liew YW; Tanner MJ
    Blood; 1991 Dec; 78(12):3291-7. PubMed ID: 1720702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor.
    Daniels GL; Green CA; Powell RM; Ward T
    Transfusion; 1998 Apr; 38(4):332-6. PubMed ID: 9595014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cromer-related blood group antigens and the glycosyl phosphatidylinositol-linked protein, decay-accelerating factor DAF (CD55).
    Reid ME
    Immunohematology; 1990; 6(2):27-9. PubMed ID: 15945985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC.
    Matthes T; Tullen E; Poole J; Banks J; Nagy M; Stelling MJ; Boehlen F; Michel M; Beris P; Hustinx H; Crew V; Daniels G
    Transfusion; 2002 Nov; 42(11):1448-57. PubMed ID: 12421218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype.
    Wang L; Uchikawa M; Tsuneyama H; Tokunaga K; Tadokoro K; Juji T
    Blood; 1998 Jan; 91(2):680-4. PubMed ID: 9427725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.
    Telen MJ; Rao N; Udani M; Thompson ES; Kaufman RM; Lublin DM
    Blood; 1994 Nov; 84(9):3205-11. PubMed ID: 7524769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Inab phenotype: characterization of the membrane protein and complement regulatory defect.
    Telen MJ; Green AM
    Blood; 1989 Jul; 74(1):437-41. PubMed ID: 2473800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.